Investigations will continue into the basic mechanisms of host defenses to Salmonella infection in mice, as a model of human typhoid fever. Mice in the C3H lineage will be immunized with a vaccine strain of live, attenuated Salmonella which induces very high levels of protection against virulent challenge and concomitant marked immunosuppression. Although it is not known if T-cells can protect of suppress, macrophages have been shown to at least partially mediate both phenomena. To explore further the role of T-cells, cloned lines will be developed in vitro and tested for antigenic specificity and capacity to transfer Salmonella immunity. As macrophages have been shown to have protective and suppressive capacity, subsets of splenic and peritoneal macrophages from vaccinated and control mice will be purified and compared, to determine if these activities reside in the same or different populations. The cells mediating the immunosuppression, and the mechanisms involved, will be further investigated using an in vitro system of antibody formation. These studies should lead to a better understanding of the mechanisms of immunity to systemic Salmonella infection and provide a theoretical framework for development of an improved typhoid vaccine.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI015613-09
Application #
3126278
Study Section
Bacteriology and Mycology Subcommittee 1 (BM)
Project Start
1978-12-01
Project End
1991-08-31
Budget Start
1988-09-01
Budget End
1989-08-31
Support Year
9
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Temple University
Department
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Eisenstein, T K (2001) Implications of Salmonella-induced nitric oxide (NO) for host defense and vaccines: NO, an antimicrobial, antitumor, immunosuppressive and immunoregulatory molecule. Microbes Infect 3:1223-31
MacFarlane, A S; Schwacha, M G; Eisenstein, T K (1999) In vivo blockage of nitric oxide with aminoguanidine inhibits immunosuppression induced by an attenuated strain of Salmonella typhimurium, potentiates Salmonella infection, and inhibits macrophage and polymorphonuclear leukocyte influx into the spleen. Infect Immun 67:891-8
Schwacha, M G; Meissler Jr, J J; Eisenstein, T K (1998) Salmonella typhimurium infection in mice induces nitric oxide-mediated immunosuppression through a natural killer cell-dependent pathway. Infect Immun 66:5862-6
Eisenstein, T K; Meissler Jr, J J; Miller, S I et al. (1998) Immunosuppression and nitric oxide production induced by parenteral live Salmonella vaccines do not correlate with protective capacity: a phoP::Tn10 mutant does not suppress but does protect. Vaccine 16:24-32
MacFarlane, A S; Huang, D; Schwacha, M G et al. (1998) Nitric oxide mediates immunosuppression induced by Listeria monocytogenes infection: quantitative studies. Microb Pathog 25:267-77
Schwacha, M G; Eisenstein, T K (1997) Interleukin-12 is critical for induction of nitric oxide-mediated immunosuppression following vaccination of mice with attenuated Salmonella typhimurium. Infect Immun 65:4897-903
Huang, D; Schwacha, M G; Eisenstein, T K (1996) Attenuated Salmonella vaccine-induced suppression of murine spleen cell responses to mitogen is mediated by macrophage nitric oxide: quantitative aspects. Infect Immun 64:3786-92
Wallace, P K; Eisenstein, T K; Meissler Jr, J J et al. (1995) Decreases in macrophage mediated antitumor activity with aging. Mech Ageing Dev 77:169-84
Eisenstein, T K (1994) Suppressor macrophages. Immunol Ser 60:203-24
Wu, L; Morahan, P S; Hendrzak, J A et al. (1994) Herpes simplex virus type 1 replication and IL-1 beta gene expression in mouse peritoneal macrophages activated in vivo by an attenuated Salmonella typhimurium vaccine or Corynebacterium parvum. Microb Pathog 16:387-99

Showing the most recent 10 out of 25 publications